Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 441

1.

Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies.

Seto NL, Torres-Ruiz JJ, Carmona-Rivera C, Pinal-Fernandez I, Pak K, Purmalek MM, Hosono Y, Fernandes-Cerqueira C, Gowda PC, Arnett N, Gorbach A, Benveniste O, Gómez-Martín D, Selva-O'Callaghan A, Milisenda JC, Grau-Junyent JM, Christopher-Stine L, Miller FW, Lundberg IE, Kahlenberg JM, Schiffenbauer AI, Mammen AL, Rider LG, Kaplan MJ.

JCI Insight. 2020 Jan 16. pii: 134189. doi: 10.1172/jci.insight.134189. [Epub ahead of print]

2.

Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses.

Adams RA, Fernandes-Cerqueira C, Notarnicola A, Mertsching E, Xu Z, Lo WS, Ogilvie K, Chiang KP, Ampudia J, Rosengren S, Cubitt A, King DJ, Mendlein JD, Yang XL, Nangle LA, Lundberg IE, Jakobsson PJ, Schimmel P.

Cell Mol Immunol. 2019 Dec 4. doi: 10.1038/s41423-019-0331-0. [Epub ahead of print]

PMID:
31797905
3.

Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis.

Betteridge Z, Chinoy H, Vencovsky J, Winer J, Putchakayala K, Ho P, Lundberg I, Danko K, Cooper R, McHugh N.

Rheumatology (Oxford). 2019 Sep 17. pii: kez406. doi: 10.1093/rheumatology/kez406. [Epub ahead of print]

PMID:
31728542
4.

Injury coding in a national trauma registry: a one-year validation audit in a level 1 trauma centre.

Bågenholm A, Lundberg I, Straume B, Sundset R, Bartnes K, Ingebrigtsen T, Dehli T.

BMC Emerg Med. 2019 Oct 30;19(1):61. doi: 10.1186/s12873-019-0276-8.

5.

Response to: 'Comment on: standardisation of myositis-specific antibodies: where are we today?' by Infantino et al.

Rönnelid J, Espinosa-Ortega F, Lundberg IE.

Ann Rheum Dis. 2019 Oct 15. pii: annrheumdis-2019-216248. doi: 10.1136/annrheumdis-2019-216248. [Epub ahead of print] No abstract available.

PMID:
31615753
6.

Idiopathic Inflammatory Myopathies.

Vencovský J, Alexanderson H, Lundberg IE.

Rheum Dis Clin North Am. 2019 Nov;45(4):569-581. doi: 10.1016/j.rdc.2019.07.006. Review.

PMID:
31564297
7.

Reproductive Pattern in Women with Idiopathic Inflammatory Myopathy - a Population-based Study.

Che WI, Hellgren K, Lundberg IE, Holmqvist M.

J Rheumatol. 2019 Aug 15. pii: jrheum.190474. doi: 10.3899/jrheum.190474. [Epub ahead of print]

PMID:
31416924
8.

Proinflammatory Histidyl-Transfer RNA Synthetase-Specific CD4+ T Cells in the Blood and Lungs of Patients With Idiopathic Inflammatory Myopathies.

Galindo-Feria AS, Albrecht I, Fernandes-Cerqueira C, Notarnicola A, James EA, Herrath J, Dastmalchi M, Sandalova T, Rönnblom L, Jakobsson PJ, Fathi M, Achour A, Grunewald J, Malmström V, Lundberg IE.

Arthritis Rheumatol. 2020 Jan;72(1):179-191. doi: 10.1002/art.41075. Epub 2019 Nov 26.

PMID:
31403245
9.

Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.

Tengvall K, Huang J, Hellström C, Kammer P, Biström M, Ayoglu B, Lima Bomfim I, Stridh P, Butt J, Brenner N, Michel A, Lundberg K, Padyukov L, Lundberg IE, Svenungsson E, Ernberg I, Olafsson S, Dilthey AT, Hillert J, Alfredsson L, Sundström P, Nilsson P, Waterboer T, Olsson T, Kockum I.

Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):16955-16960. doi: 10.1073/pnas.1902623116. Epub 2019 Aug 2.

PMID:
31375628
10.

Anti-transcriptional intermediary factor 1 gamma antibodies in cancer-associated myositis: a longitudinal study.

Dani L, Holmqvist M, Martínez MA, Trallero-Araguas E, Dastmalchi M, Svensson J, Labrador-Horrillo M, Selva-O'Callaghan A, Lundberg IE.

Clin Exp Rheumatol. 2019 Jul 30. [Epub ahead of print]

PMID:
31365334
11.

Response to: 'Semi-quantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance?' by Cavazzana et al.

Rönnelid J, Espinosa-Ortega F, Lundberg IE.

Ann Rheum Dis. 2019 Jul 15. pii: annrheumdis-2019-215967. doi: 10.1136/annrheumdis-2019-215967. [Epub ahead of print] No abstract available.

PMID:
31308067
12.

Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble.

Tanboon J, Sanmaneechai O, Charuvanij S, Sangruchi T, Galindo-Feria AS, Lundberg IE, Ohnuki Y, Shiina T, Suzuki S, Nishino I.

Neuromuscul Disord. 2019 Jul;29(7):543-548. doi: 10.1016/j.nmd.2019.05.007. Epub 2019 May 23.

PMID:
31204143
13.

Features of repeated muscle biopsies and phenotypes of monocytes in paired blood samples and clinical long-term response to treatment in patients with idiopathic inflammatory myopathy: a pilot study.

Tang Q, Gheorghe KR, Zhang XM, Lindroos E, Alexanderson H, Wick C, Bruton M, Fernandes-Cerqueira C, Harris RA, Nennesmo I, Lundberg IE.

Clin Exp Rheumatol. 2019 May 22. [Epub ahead of print]

PMID:
31140400
14.

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups.

Rothwell S, Chinoy H, Lamb JA, Miller FW, Rider LG, Wedderburn LR, McHugh NJ, Mammen AL, Betteridge ZE, Tansley SL, Bowes J, Vencovský J, Deakin CT, Dankó K, Vidya L, Selva-O'Callaghan A, Pachman LM, Reed AM, Molberg Ø, Benveniste O, Mathiesen PR, Radstake TRDJ, Doria A, de Bleecker J, Lee AT, Hanna MG, Machado PM, Ollier WE, Gregersen PK, Padyukov L, O'Hanlon TP, Cooper RG, Lundberg IE; Myositis Genetics Consortium (MYOGEN).

Ann Rheum Dis. 2019 Jul;78(7):996-1002. doi: 10.1136/annrheumdis-2019-215046. Epub 2019 May 28.

15.

Mitochondrial dysfunction and role of harakiri in the pathogenesis of myositis.

Boehler JF, Horn A, Novak JS, Li N, Ghimbovschi S, Lundberg IE, Alexanderson H, Alemo Munters L, Jaiswal JK, Nagaraju K.

J Pathol. 2019 Oct;249(2):215-226. doi: 10.1002/path.5309. Epub 2019 Jul 18.

PMID:
31135059
16.

Response to: 'Response to: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco et al' by Knitza et al.

Tjärnlund A, Lundberg IE.

Ann Rheum Dis. 2019 May 8. pii: annrheumdis-2019-215515. doi: 10.1136/annrheumdis-2019-215515. [Epub ahead of print] No abstract available.

PMID:
31068326
17.

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.

Betteridge Z, Tansley S, Shaddick G, Chinoy H, Cooper RG, New RP, Lilleker JB, Vencovsky J, Chazarain L, Danko K, Nagy-Vincze M, Bodoki L, Dastmalchi M, Ekholm L, Lundberg IE, McHugh N; UKMyonet contributors.

J Autoimmun. 2019 Jul;101:48-55. doi: 10.1016/j.jaut.2019.04.001. Epub 2019 Apr 13.

18.

Myositis an evolving spectrum of disease.

Barsotti S, Lundberg IE.

Immunol Med. 2018 Jun;41(2):46-54. doi: 10.1080/13497413.2018.1481571. Epub 2018 Sep 11.

PMID:
30938263
19.

Acute Coronary Syndrome in Idiopathic Inflammatory Myopathies: A Population-based Study.

Leclair V, Svensson J, Lundberg IE, Holmqvist M.

J Rheumatol. 2019 Nov;46(11):1509-1514. doi: 10.3899/jrheum.181248. Epub 2019 Mar 15.

PMID:
30877220
20.

OMERACT 2018 Modified Patient-reported Outcome Domain Core Set in the Life Impact Area for Adult Idiopathic Inflammatory Myopathies.

Regardt M, Mecoli CA, Park JK, de Groot I, Sarver C, Needham M, de Visser M, Shea B, Bingham CO 3rd, Lundberg IE, Song YW, Christopher-Stine L, Alexanderson H.

J Rheumatol. 2019 Oct;46(10):1351-1354. doi: 10.3899/jrheum.181065. Epub 2019 Feb 15.

PMID:
30770504
21.

Comparison of autoantibody specificities tested by a line blot assay and immunoprecipitation-based algorithm in patients with idiopathic inflammatory myopathies.

Espinosa-Ortega F, Holmqvist M, Alexanderson H, Storfors H, Mimori T, Lundberg IE, Rönnelid J.

Ann Rheum Dis. 2019 Jun;78(6):858-860. doi: 10.1136/annrheumdis-2018-214690. Epub 2019 Feb 13. No abstract available.

PMID:
30760469
22.

Efficacy and safety of rituximab in anti-synthetase antibody positive and negative subjects with idiopathic inflammatory myopathy: a registry-based study.

Leclair V, Galindo-Feria AS, Dastmalchi M, Holmqvist M, Lundberg IE.

Rheumatology (Oxford). 2019 Jul 1;58(7):1214-1220. doi: 10.1093/rheumatology/key450.

PMID:
30690633
23.

Current Treatment for Myositis.

Barsotti S, Lundberg IE.

Curr Treatm Opt Rheumatol. 2018;4(4):299-315. doi: 10.1007/s40674-018-0106-2. Epub 2018 Sep 15. Review.

24.

Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies.

Fernandes-Cerqueira C, Renard N, Notarnicola A, Wigren E, Gräslund S, Zubarev RA, Lundberg IE, Lundström SL.

Sci Rep. 2018 Dec 18;8(1):17958. doi: 10.1038/s41598-018-36395-z.

25.

A Research Note on the Prevalence of Housing Eviction Among Children Born in U.S. Cities.

Lundberg I, Donnelly L.

Demography. 2019 Feb;56(1):391-404. doi: 10.1007/s13524-018-0735-y.

PMID:
30484162
26.

Long-term, health-enhancing physical activity is associated with reduction of pain but not pain sensitivity or improved exercise-induced hypoalgesia in persons with rheumatoid arthritis.

Löfgren M, Opava CH, Demmelmaier I, Fridén C, Lundberg IE, Nordgren B, Kosek E.

Arthritis Res Ther. 2018 Nov 26;20(1):262. doi: 10.1186/s13075-018-1758-x.

27.

Effect of CTLA4-Ig (abatacept) treatment on T cells and B cells in peripheral blood of patients with polymyositis and dermatomyositis.

Tang Q, Ramsköld D, Krystufkova O, Mann HF, Wick C, Dastmalchi M, Lakshmikanth T, Chen Y, Mikes J, Alexanderson H, Achour A, Brodin P, Vencovsky J, Lundberg IE, Malmström V.

Scand J Immunol. 2019 Jan;89(1):e12732. doi: 10.1111/sji.12732. Epub 2018 Dec 9.

28.

Clinical phenotype, autoantibody profile and HLA-DR-type in Vietnamese patients with idiopathic inflammatory myopathies.

Nguyen Thi Phuong T, Nguyen Thi Ngoc L, Nguyen Xuan H, Rönnelid J, Padyukov L, Lundberg IE.

Rheumatology (Oxford). 2019 Feb 1;58(2):361-363. doi: 10.1093/rheumatology/key313. No abstract available.

PMID:
30371850
29.

Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT Study.

Mecoli CA, Park JK, Alexanderson H, Regardt M, Needham M, de Groot I, Sarver C, Lundberg IE, Shea B, de Visser M, Song YW, Bingham CO 3rd, Christopher-Stine L.

J Rheumatol. 2019 Jan;46(1):106-111. doi: 10.3899/jrheum.180353. Epub 2018 Sep 15.

PMID:
30219767
30.

T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients.

Houtman M, Ekholm L, Hesselberg E, Chemin K, Malmström V, Reed AM, Lundberg IE, Padyukov L.

Arthritis Res Ther. 2018 Aug 29;20(1):188. doi: 10.1186/s13075-018-1688-7.

31.

Expression of interleukin-18 in muscle tissue of patients with polymyositis or dermatomyositis and effects of conventional immunosuppressive treatment.

Helmers SB, Bruton M, Loell I, Ulfgren AK, Gracie AJ, McInnes IB, Lundberg IE.

Rheumatology (Oxford). 2018 Dec 1;57(12):2149-2157. doi: 10.1093/rheumatology/key222.

PMID:
30102381
32.

Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis.

Kryštůfková O, Hulejová H, Mann HF, Pecha O, Půtová I, Ekholm L, Lundberg IE, Vencovský J.

Arthritis Res Ther. 2018 Jul 27;20(1):158. doi: 10.1186/s13075-018-1650-8.

33.

The Risk of Ischemic and Hemorrhagic Stroke in Patients With Idiopathic Inflammatory Myopathies: A Swedish Population-Based Cohort Study.

Moshtaghi-Svensson J, Lundberg IE, Von Euler M, Arkema EV, Holmqvist M.

Arthritis Care Res (Hoboken). 2019 Jul;71(7):970-976. doi: 10.1002/acr.23702.

PMID:
29999244
34.

Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study.

Park JK, Mecoli CA, Alexanderson H, Regardt M, Christopher-Stine L, Casal-Domínguez M, de Groot I, Sarver C, Lundberg IE, Bingham CO 3rd, Song YW.

J Rheumatol. 2018 Jul;45(7):1071. doi: 10.3899/jrheum.161252.C2. No abstract available.

PMID:
29961681
35.

PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients.

Steneberg P, Lindahl E, Dahl U, Lidh E, Straseviciene J, Backlund F, Kjellkvist E, Berggren E, Lundberg I, Bergqvist I, Ericsson M, Eriksson B, Linde K, Westman J, Edlund T, Edlund H.

JCI Insight. 2018 Jun 21;3(12). pii: 99114. doi: 10.1172/jci.insight.99114. eCollection 2018 Jun 21.

36.

Impaired left atrial dynamics and its improvement by guided physical activity reveal left atrial strain as a novel early indicator of reversible cardiac dysfunction in rheumatoid arthritis.

Venkateshvaran A, Sarajlic P, Lund LH, Fridén C, Nordgren B, Opava CH, Lundberg IE, Larsson SC, Manouras A, Bäck M.

Eur J Prev Cardiol. 2018 Jul;25(10):1106-1108. doi: 10.1177/2047487318777775. Epub 2018 May 25. No abstract available.

PMID:
29799295
37.

Response to: 'Time to personalise the treatment of anti-MDA-5 associated lung disease' by Lake et al.

Leclair V, Lundberg IE, Tjärnlund A.

Ann Rheum Dis. 2019 Jun;78(6):e53. doi: 10.1136/annrheumdis-2018-213519. Epub 2018 May 3. No abstract available.

PMID:
29724727
38.

Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis.

Raouf J, Idborg H, Englund P, Alexanderson H, Dastmalchi M, Jakobsson PJ, Lundberg IE, Korotkova M.

Arthritis Res Ther. 2018 May 2;20(1):83. doi: 10.1186/s13075-018-1579-y.

39.

An Outsourced Health-enhancing Physical Activity Program for People with Rheumatoid Arthritis: Study of the Maintenance Phase.

Nordgren B, Fridén C, Demmelmaier I, Bergström G, Lundberg IE, Nessen T, Dufour AB, Opava CH; PARA Study Group.

J Rheumatol. 2018 Aug;45(8):1093-1100. doi: 10.3899/jrheum.171002. Epub 2018 May 1.

PMID:
29717033
40.

Classification of myositis.

Lundberg IE, de Visser M, Werth VP.

Nat Rev Rheumatol. 2018 May;14(5):269-278. doi: 10.1038/nrrheum.2018.41. Epub 2018 Apr 12. Review.

PMID:
29651121
41.

Response to: 'Detection of myositis-specific antibodies: additional notes' by Infantino et al.

Tjärnlund A, Lundberg IE, Rönnelid J.

Ann Rheum Dis. 2019 Apr;78(4):e30. doi: 10.1136/annrheumdis-2018-213341. Epub 2018 Apr 3. No abstract available.

PMID:
29615410
42.

Successful Lung Transplantation in a Case of Rapidly Progressive Interstitial Lung Disease Associated with Antimelanoma Differentiation-associated Gene 5 Antibodies.

Leclair V, Labirua-Iturburu A, Lundberg IE.

J Rheumatol. 2018 Apr;45(4):581-583. doi: 10.3899/jrheum.171047. No abstract available.

PMID:
29606647
43.

Venous Thromboembolic Events in Idiopathic Inflammatory Myopathy: Occurrence and Relation to Disease Onset.

Antovic A, Notarnicola A, Svensson J, Lundberg IE, Holmqvist M.

Arthritis Care Res (Hoboken). 2018 Dec;70(12):1849-1855. doi: 10.1002/acr.23560.

44.

New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter.

Leclair V, Lundberg IE.

Curr Rheumatol Rep. 2018 Mar 17;20(4):18. doi: 10.1007/s11926-018-0726-4. Review.

45.

Pain sensitivity at rest and during muscle contraction in persons with rheumatoid arthritis: a substudy within the Physical Activity in Rheumatoid Arthritis 2010 study.

Löfgren M, Opava CH, Demmelmaier I, Fridén C, Lundberg IE, Nordgren B, Kosek E.

Arthritis Res Ther. 2018 Mar 15;20(1):48. doi: 10.1186/s13075-018-1513-3.

46.

Reply.

Tjärnlund A, Bottai M, Lundberg IE.

Arthritis Rheumatol. 2018 Jun;70(6):976. doi: 10.1002/art.40473. Epub 2018 May 2. No abstract available.

47.

Increasing Reasoning Awareness: Video Analysis of Students' Two-Party Virtual Patient Interactions.

Edelbring S, Parodis I, Lundberg IE.

JMIR Med Educ. 2018 Feb 27;4(1):e4. doi: 10.2196/mededu.9137.

48.

Muscle Strength and Muscle Endurance During the First Year of Treatment of Polymyositis and Dermatomyositis: A Prospective Study.

Alexanderson H, Regardt M, Ottosson C, Alemo Munters L, Dastmalchi M, Dani L, Lundberg IE.

J Rheumatol. 2018 Apr;45(4):538-546. doi: 10.3899/jrheum.161183. Epub 2018 Feb 1.

PMID:
29419464
49.

Response to: 'Detection of myositis-specific antibodies' by Vulsteke et al.

Tjärnlund A, Rönnelid J, Bottai M, Lundberg IE.

Ann Rheum Dis. 2019 Jan;78(1):e8. doi: 10.1136/annrheumdis-2018-212948. Epub 2018 Jan 30. No abstract available.

PMID:
29382639
50.

MicroRNA Expression in KRAS- and BRAF-mutated Colorectal Cancers.

Lundberg IV, Wikberg ML, Ljuslinder I, Li X, Myte R, Zingmark C, Löfgren-Burström A, Edin S, Palmqvist R.

Anticancer Res. 2018 Feb;38(2):677-683.

PMID:
29374690

Supplemental Content

Loading ...
Support Center